THEODORE S LAWRENCE, MD
Radiology in Ann Arbor, MI

License number
Michigan 4301050925
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Michigan 4301050925
Category
Osteopathic Medicine
Type
Medical Oncology
License number
Michigan 4301050925
Category
Radiology
Type
Radiation Oncology
Address
Address
1500 Floor University Hospital RM C490, Ann Arbor, MI 48109
Phone
(734) 936-4300
(734) 936-2047

Personal information

See more information about THEODORE S LAWRENCE at radaris.com
Name
Address
Phone
Theodore Lawrence, age 64
3902 Bristol Oak St, Dowling, MI 49050
(269) 721-4147
Theodore Lawrence, age 98
4040 Greenleaf Cir APT 404, Kalamazoo, MI 49008
(269) 719-6869
Theodore Lawrence
6048 N Gulley Rd, Dearborn Hts, MI 48127
(313) 492-2553
Theodore Lawrence, age 54
33825 W Jefferson Ave, Brownstown Township, MI 48173
Theodore Lawrence, age 51
714 Indianola Ave, Ann Arbor, MI 48105

Professional information

See more information about THEODORE S LAWRENCE at trustoria.com
Theodore S Lawrence Photo 1
Theodore S Lawrence, Ann Arbor MI

Theodore S Lawrence, Ann Arbor MI

Specialties:
Oncologist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
Cornell University, Weill Cornell Medical College - Doctor of Medicine
National Institutes of Health-Clinical Center - Fellowship - Oncology (Internal Medicine)
National Institutes of Health-Clinical Center - Residency - Radiation Oncology
Stanford Hospital & Clinics - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine), American Board of Radiology Certification in Radiation Oncology (Radiology)


Theodore Lawrence Photo 2
Theodore Lawrence, Ann Arbor MI

Theodore Lawrence, Ann Arbor MI

Specialties:
Internal Medicine, Medical Oncology, Radiation Oncology, Therapeutic Radiology
Work:
Va Ann Arbor Healthcare System
2215 Fuller Rd, Ann Arbor, MI 48105 Regents of University Michigan
1500 E Medical Center Dr, Ann Arbor, MI 48109 Mohamed Khan, MD
1501 W Chisholm St, Alpena, MI 49707 Molly A Sullivan MD Group
1221 South Dr, Mount Pleasant, MI 48858 Radiation Oncology
47601 Grand River Ave, Novi, MI 48374
Education:
Cornell University (1980)


Theodore S Lawrence Photo 3
Dr. Theodore S Lawrence, Ann Arbor MI - MD (Doctor of Medicine)

Dr. Theodore S Lawrence, Ann Arbor MI - MD (Doctor of Medicine)

Specialties:
Oncology, Medical Oncology
Address:
University Of Michigan Rad Onc
1500 E Medical Center Dr SUITE 5014, Ann Arbor 48109
(734) 936-4300 (Phone)
Certifications:
Internal Medicine, 1983, Medical Oncology, 1985, Radiation Oncology
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University Of Michigan Rad Onc
1500 E Medical Center Dr SUITE 5014, Ann Arbor 48109
Sisters of Charity Providence Hospitals
2435 Forest Dr, Columbia 29204
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
Weill Cornell Medical College
Graduated: 1980
Stanford University
Nci


Theodore Lawrence Photo 4
Inhibitors Of The Epidermal Growth Factor Receptor-Heat Shock Protein 90 Binding Interaction

Inhibitors Of The Epidermal Growth Factor Receptor-Heat Shock Protein 90 Binding Interaction

US Patent:
2012019, Jul 26, 2012
Filed:
Dec 19, 2011
Appl. No.:
13/329800
Inventors:
Mukesh K. Nyati - Ann Arbor MI, US
Theodore S. Lawrence - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 38/08, A61P 35/00, A61K 38/07
US Classification:
514 96
Abstract:
Provided herein are compounds that inhibit a binding interaction between an epidermal growth factor receptor (EGFR) and a heat shock protein 90 (HSP90), as well as compositions, e.g., pharmaceutical compositions, comprising the same, and related kits. In some embodiments, the compound is an antibody or antibody analog, and, in other embodiments, the compound is a peptide or peptide analog. Also provided are methods of using the compounds, including methods of increasing degradation of an EGFR, methods of treating cancer, and methods of sensitizing tumors to radiation therapy.